Zevra Therapeutics, Inc. (ZVRA)
NASDAQ·Healthcare·Biotechnology
$12.67
-2.39%
Mkt Cap $627.21M
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (13 analysts)
$25.50
Range $25.00 – $26.00
Implied Upside
+101.3%
Consensus $25.50 vs current $12.67
NASDAQ·Healthcare·Biotechnology
$12.67
-2.39%
Mkt Cap $627.21M
Buy
6
Hold
0
Sell
0
Price Target (13 analysts)
$25.50
Range $25.00 – $26.00
+101.3%
Consensus $25.50 vs current $12.67